| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/24/2008 | CA2673770A1 Human erythrovirus |
| 07/23/2008 | EP1947185A1 HCV NS3/4A encoding nucleic acid |
| 07/23/2008 | EP1947181A1 Mutant paramyxovirus and method for production thereof |
| 07/23/2008 | EP1947174A1 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 07/23/2008 | EP1947112A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/23/2008 | EP1945811A2 Systems for detection and production of respiratory, herpes and enteric viruses |
| 07/23/2008 | EP1945659A2 Influenza viruses able to infect canids, uses thereof |
| 07/23/2008 | EP1945255A2 Radiating element for radar array antenna |
| 07/23/2008 | EP1945250A2 Influenza recombinant subunit vaccine |
| 07/23/2008 | EP1082413B1 Aav5 vector and uses thereof |
| 07/23/2008 | CN101228267A Cell line for producing coronaviruses |
| 07/23/2008 | CN101225403A Small interfering RNA recombinant adenovirus for targeting epidermal growth factor receptor and use thereof |
| 07/23/2008 | CN100404683C Human FL polynucleotide and use of human GM-CSF united gene therewith for treating malignant tumor |
| 07/23/2008 | CN100404669C Novel reovirus, its antibody and vaccine and use thereof |
| 07/23/2008 | CN100404667C Young beet armyworms fat body cell system for producing baculiform virus with high yields |
| 07/23/2008 | CN100404070C Packaged virus-like particles |
| 07/22/2008 | US7402429 Stably transfected plasmids that express polymerase, viral proteins from measles or mumps; Paramyxoviridae; use in vaccines or gene therapy |
| 07/22/2008 | US7402310 Deoxyribonuclease, gene encoding same and use thereof |
| 07/22/2008 | CA2282706C Adenovirus vectors specific for cells expressing .alpha.-fetoprotein and methods of use thereof |
| 07/22/2008 | CA2274474C Synthetic hpv16 virus-like particles |
| 07/17/2008 | WO2008085486A1 Herpes simplex virus combined subunit vaccines and methods of use thereof |
| 07/17/2008 | WO2007057763A3 Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant |
| 07/17/2008 | US20080171390 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 07/17/2008 | US20080171376 Modified bacteriocins and methods for their use |
| 07/17/2008 | US20080171358 Expression System |
| 07/17/2008 | US20080171313 Identifying nucleoside resistant hepatitis b virus based on presence of mutation in polymerase gene |
| 07/17/2008 | US20080171018 Serotype of adenovirus and uses thereof |
| 07/17/2008 | DE102007003148A1 Gentechnisch modifizierte Bakteriophagen, insbesondere zur Bekämpfung von pathogenen Prokaryonten bzw. ihrer pathologischen Wirkung, sowie deren Verwendung und Herstellung Genetically modified bacteriophage, particularly for combating pathogenic prokaryotes and their pathological effects, and their use and production |
| 07/16/2008 | EP1944362A2 Methods for generating high titer helper-free preparations of recombinant AAV vectors |
| 07/16/2008 | EP1944312A1 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 07/16/2008 | EP1944043A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 07/16/2008 | EP1797175B1 Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection |
| 07/16/2008 | CN101220351A Method for constructing PRRSV gene deletion vaccine toxin strain by using Nsp2 gene deletion and uses thereof |
| 07/16/2008 | CN101220350A Separated Listeria monocytogenes bacterial virus and uses thereof |
| 07/16/2008 | CN101220349A Separated coliphage and application as biological fungicide in foods and anti-infection contamination thereof |
| 07/16/2008 | CN101220348A Pig replication and respiration syndrome virus attenuated vaccine strain and uses thereof |
| 07/16/2008 | CN100402651C Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 07/16/2008 | CN100402643C 感染性克隆 Infectious clone |
| 07/15/2008 | US7399477 Genome segment, vaccine; temperature sensitivity, dominant interference, or attenuation; therapeutics, to protect animals from diseases caused by influenza A viruses, and in particular, to protect horses from disease caused by equine influenza virus |
| 07/10/2008 | US20080166797 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 07/10/2008 | US20080166785 Polynucleotides allowing the expression and secretion of recombinant HBsAg virus-like particles containing a foreign peptide, their production and use |
| 07/10/2008 | US20080166784 Preparing preservative mixture for storage of newcastle disease virus |
| 07/10/2008 | US20080166758 Viral vectors comprising heterologous gene sequences for transfer and propagation in host cells |
| 07/10/2008 | US20080166754 Plant caffeic acid-3-O-methyltransferase homologs |
| 07/10/2008 | US20080166700 Using viral reporter expression as evaluative tool in detecting bacterial cells in food products |
| 07/10/2008 | US20080166322 Using recombinant vector comprising defective e5 gene as tool for heterologous gene transfer; gene therapy |
| 07/09/2008 | EP1942191A1 Nucleic acid construct containing full-length genome of human hepatitis C virus, recombinant full-length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 07/09/2008 | EP1942182A2 Vero cell line which is adapted to grow in suspension, method of obtaining same and viral vaccines |
| 07/09/2008 | EP1941033A2 Compositions and methods for the treatment of canine influenza virus disease |
| 07/09/2008 | EP1940414A2 Anti mineralocorticoid therapy of infection |
| 07/09/2008 | EP1337626B1 Bacteriophage composition useful in treating food products to prevent bacterial contamination |
| 07/09/2008 | EP1156813B1 Reovirus for the treatment of cellular proliferative disorders |
| 07/09/2008 | EP0476130B1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 07/09/2008 | CN101215577A General purpose method for preparing integration type cell immortalization vector |
| 07/09/2008 | CN101215552A F-genetype parotitis attenuated virus strain and use thereof |
| 07/09/2008 | CN101215551A Tissue culture bulb preserving method for narcissus pseudonarcissus virus |
| 07/09/2008 | CN101215550A Tissue culture bulb preserving method for thunberg fritillary virus |
| 07/09/2008 | CN100400101C Vaccines containing ribavirin and methods of use thereof |
| 07/08/2008 | CA2209135C Human immunodeficiency virus vaccines and therapeutics containing replication-impaired hiv-1 nef-deletion mutants |
| 07/03/2008 | WO2008080003A2 Generation of oncolytic adenoviruses and uses thereof |
| 07/03/2008 | WO2008079539A2 Recombinant herpesvirus with diminished latency and methods of using same |
| 07/03/2008 | US20080160514 Using carbon dioxide to maintain hydrogen ion concentration of cellulosic pulp/biomass comprising hydrolytic enzymes; papermaking; cellulosic pulp bleaching; rayon or lyocell production |
| 07/03/2008 | US20080160507 Using cell-free protein synthesis mixture for use in translation and assembly of retroviral capsid and capsid intermediate particles |
| 07/03/2008 | US20080160046 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
| 07/03/2008 | US20080160039 Pneumovirus NS proteins antagonize the interferon IFN response |
| 07/03/2008 | US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders |
| 07/03/2008 | US20080159957 administrating a non-pathogenic, insect-specific virus to induce an immune response, and effective to cause cell death in the cell; cancer vaccines and immunotherapies; immunostimulants, biodrugs |
| 07/03/2008 | DE10053781B4 Kernexportreportersystem Nuclear export reporter system |
| 07/03/2008 | CA2673520A1 Generation of oncolytic adenoviruses and uses thereof |
| 07/03/2008 | CA2673262A1 Cells and methodology to generate non-segmented negative-strand rna viruses |
| 07/02/2008 | EP1939300A1 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders |
| 07/02/2008 | EP1939290A2 Gene expression control |
| 07/02/2008 | EP1939281A1 Immortalized Avian Cell Lines for Virus Production |
| 07/02/2008 | EP1939214A1 Cells and methodology to generate non-segmented negative-strand RNA viruses |
| 07/02/2008 | EP1937810A2 Dna modular cloning vector plasmids and methods for their use |
| 07/02/2008 | EP1173585B1 Epoxide hydrolases of aspergillus origin |
| 07/02/2008 | EP0774002B1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 07/02/2008 | EP0667912B1 Defective adenovirus vectors and use thereof in gene therapy |
| 07/02/2008 | CN101213294A Scalable fermentation process |
| 07/02/2008 | CN100398642C Improvements in virus production |
| 07/01/2008 | US7393945 Estrogen receptor genes and utilization thereof |
| 07/01/2008 | US7393677 Avidin-pseudotyped viral vectors and their use |
| 07/01/2008 | US7393631 From contaminated sample using sodium chloride solution to prevent irreversible binding to hydroxyapatite; eluting and washing; reduces empty capsids and impurities |
| 07/01/2008 | US7393527 Method for limiting the growth of cancer cells using an attenuated measles virus |
| 07/01/2008 | US7393524 Baculovirus vectors comprising a capsid polypeptide fused to a GNRH polypeptide |
| 06/26/2008 | WO2008076371A2 Method for replicating influenza virus in culture |
| 06/26/2008 | WO2008074189A1 A recombinant adenovirus comprising recombinant khp50 gene and preparation method and uses thereof |
| 06/26/2008 | WO2008039357A9 Uncoupling of dna insert propagation and expression of protein for phage display |
| 06/26/2008 | WO2008011503A3 Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 06/26/2008 | WO2007120120A3 Attenuated human parainfluenza virus, methods and uses thereof |
| 06/26/2008 | US20080153770 Expression Vectors with Improved Safety |
| 06/26/2008 | US20080153082 Improved stability in high salt concentration solutions, buffers; biosensors; non-nucleotide polyphosphate polymer with a recognition probe conjugated thereto; e.g. polyanion-gold nanoparticle conjugates |
| 06/26/2008 | US20080152673 Comprising histone protein and sugar in form of amorphous solid; plant seed extract effects drying tolerance |
| 06/26/2008 | US20080152670 Attenuated; comprising at least two types of foreign genes inserted to allow expression into two different regions in a recombinant feline herpesvirus type 1 genome; one region encodes thymidine kinase; no lethal effect on the proliferation of the virus in the feline herpesvirus 1 genome |
| 06/26/2008 | CA2766173A1 Method for replicating influenza virus in culture |
| 06/26/2008 | CA2671869A1 Method for replicating influenza virus in culture |
| 06/25/2008 | EP1934343A2 Selective posttranslational modification of phage-displayed polypeptides |
| 06/25/2008 | EP1934335A2 Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications |
| 06/25/2008 | EP1933866A2 Canine influenza virus and related compositions and methods of use |
| 06/25/2008 | EP1425404B1 Vaccinia virus mva-e3l-knockout-mutants and use thereof |